A detailed history of Pacifica Partners Inc. transactions in Organon & Co. stock. As of the latest transaction made, Pacifica Partners Inc. holds 3 shares of OGN stock, worth $54. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 3 -0.0%
Holding current value
$54
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$13.78 - $18.8 $275 - $376
-20 Reduced 86.96%
3 $0
Q4 2023

Jan 05, 2024

SELL
$10.95 - $17.32 $328 - $519
-30 Reduced 56.6%
23 $0
Q3 2023

Oct 10, 2023

BUY
$16.59 - $23.77 $829 - $1,188
50 Added 1666.67%
53 $0
Q4 2022

Jan 11, 2023

SELL
$23.31 - $28.61 $116 - $143
-5 Reduced 62.5%
3 $0
Q3 2021

Oct 07, 2021

BUY
$28.63 - $35.64 $229 - $285
8 New
8 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.65B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.